As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today

Annette Tumolo Biography and Net Worth

EVP of Bio-Rad Laboratories

Annette Tumolo serves as Executive Vice President, President, Life Science Group of the Company. She was appointed Executive Vice President, President, Life Science Group in September 2017. Previously she was Executive Vice President and General Manager of the Digital Biology Group from 2015 to 2017, Senior Vice President of the Digital Biology Center from 2014 to 2015, and Vice President, Director of the Digital Biology Center from 2012 to 2014. Prior to that she held various positions within Bio-Rad since joining us in 1989, including Vice President and Division Manager of the Gene Expression Division, and Business Unit Manager of the Molecular Biology Business Unit.

What is Annette Tumolo's net worth?: The estimated net worth of Annette Tumolo is at least $1.72 million as of November 6th, 2020. Ms. Tumolo owns 5,322 shares of Bio-Rad Laboratories stock worth more than $1,722,678 as of November 21st. This net worth approximation does not reflect any other assets that Ms. Tumolo may own. Learn More about Annette Tumolo's net worth.
How do I contact Annette Tumolo?: The corporate mailing address for Ms. Tumolo and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected]. Learn More on Annette Tumolo's contact information.
Has Annette Tumolo been buying or selling shares of Bio-Rad Laboratories?: Annette Tumolo has not been actively trading shares of Bio-Rad Laboratories during the last quarter. Most recently, Annette Tumolo sold 1,546 shares of the business's stock in a transaction on Thursday, November 11th. The shares were sold at an average price of $749.00, for a transaction totalling $1,157,954.00. Learn More on Annette Tumolo's trading history.
Who are Bio-Rad Laboratories' active insiders?: Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), Ronald Hutton (VP), Giovanni Magni (EVP), Ajit Ramalingam (CAO), and Annette Tumolo (EVP). Learn More on Bio-Rad Laboratories' active insiders.
Are insiders buying or selling shares of Bio-Rad Laboratories?: In the last twelve months, insiders at the medical research company sold shares 6 times. They sold a total of 8,834 shares worth more than $2,862,606.26. The most recent insider tranaction occured on September, 6th when COO Andrew J Last sold 3,000 shares worth more than $989,820.00. Insiders at Bio-Rad Laboratories own 17.5% of the company. Learn More about insider trades at Bio-Rad Laboratories.
Information on this page was last updated on 9/6/2024.

Annette Tumolo Insider Trading History at Bio-Rad Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2021	Sell	1,546	$749.00	$1,157,954.00
8/26/2021	Sell	600	$792.58	$475,548.00
11/6/2020	Sell	1,200	$640.72	$768,864.00	5,322
12/11/2018	Sell	2,376	$254.51	$604,715.76	1,504

Annette Tumolo Buying and Selling Activity at Bio-Rad Laboratories

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Today's Range

Now: $325.04

$320.32

$326.45

50 Day Range

MA: $340.30

$313.15

$374.28

2 Week Range

Now: $325.04

$262.12

$387.99

Volume

89,385 shs

Average Volume

245,881 shs

Market Capitalization

$9.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now